Steps 8-15
IntroDuctIon
Since the initial observation that insertion of a human cytomegalovirus (CMV) promoter or a Rous sarcoma virus (RSV) promoter into an Autographa californica multiple nucleopolyhedrosis virus (AcMNPV; from here on referred to as baculovirus) transfer vector allowed for the expression of foreign genes in hepatocytes and other mammalian cell lines 1,2 , BacMam has been used for a growing number of applications. These applications include drug discovery (identification and development of new therapeutic agents) through recombinant protein expression for cell-based functional assays using G protein-coupled receptors (GPCRs) 3, 4 , nuclear receptors 5 , ion channels 6, 7 and ATP-binding cassette drug transporters 8 . More recently, BacMam has been used for large-scale protein production for crystallography [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . The success of these applications, however, depends in part on the efficient production and amplification of baculovirus and on subsequent large-scale transduction and heterologous protein expression. In addition to these challenges, obtaining sufficient quantities of membrane protein for crystallography is frequently compounded by low levels of expression and instability of the candidate membrane protein, thus requiring screening of many constructs. Furthermore, some mammalian membrane proteins require specific post-translational modifications and a near-native lipid environment, thus rendering expression in insect cells or in yeast untenable. Taken together, these complexities can result in a high cost for heterologous membrane protein expression in mammalian cells, and thus improving the efficiency of the process is important.
Here we describe methods for screening constructs and optimizing heterologous expression of membrane proteins from BacMam-transduced HEK293S GnTI − (N-acetylglucosaminyltransferase I-negative) cells for purification and crystallization (Fig. 1) . We have constructed a vector (pEG BacMam) for high-level expression in mammalian cells using elements derived from a previously described vector, pVLAD 10 . Once genes of candidate membrane proteins are fused in frame with a GFP tag and cloned into pEG BacMam, they can be rapidly screened for expression and monodispersity using transient transfection in adherent cells coupled with FSEC 21, 22 . We also optimized virus amplification and protein expression protocols such that the cost and time for expressing most of the membrane proteins in HEK293 GnTI − cells are similar to or better than those of expression in Sf9 cells.
This protocol is exemplified using two proteins expressed in mammalian cells: Gallus gallus cASIC1 (refs. 16,23) and C. elegans GluCl 24, 25 . This protocol is now in standard use in our laboratory for mammalian-expressed membrane proteins [15] [16] [17] 20 .
high-level protein expression in mammalian cells with the ability to express multiprotein complexes from a single vector (Fig. 2) . To do this, we chemically synthesized genetic elements derived from the previously described BacMam vector pVLAD 10 , which include a strong CMV promoter for robust transcription, a synthetic intron for efficient RNA splicing and mRNA processing, and a WPRE motif for efficient mRNA processing, stability and export. These chemically synthesized elements were combined with the pFBDM (ref. 26 ), a bicistronic vector with a restriction enzyme module that allows the assembly of multiple expression cassettes, to generate pEG BacMam. After the gene of interest is cloned into pEG BacMam, we screen constructs by small-scale transfection/FSEC before moving to the time-consuming process of virus amplification 21 .
In our research to optimize protein expression, we compared the expression of cASIC1 and GluCl in mammalian cells and insect cells. We show that fivefold more GluCl pentamer can be obtained in mammalian cells. In the case of cASIC1, not only can twofold more trimer be obtained in mammalian cells but also the protein is more monodisperse and experiences less spontaneous cleavage of the GFP-His 8 tag.
Although other HEK cell lines can be used, for screening and expression we typically use HEK293S GnTI − cells, a mammalian cell line that expresses proteins that are more mannose-rich and are thus easily removed using endoglycosidases such as EndoH (ref. 27) . Although the use of these cells and EndoH can reduce the heterogeneity caused by complex glycans that can create problems in crystallographic studies, it may not be beneficial for every protein. Therefore, it is advantageous to test protein expression in other mammalian cell lines, as well as to determine whether the use of EndoH affects the solubility and the heterogeneity of the glycoprotein.
To determine the expression level and monodispersity of the candidate membrane protein, HEK293S GnTI − cells are transfected with the pEG BacMam plasmid containing the gene of interest; collected after 48 h; and then solubilized in a buffer containing n-dodecyl-β-d-maltoside (C 12 M), maltoseneopentyl glycol 28 (MNG-3), or other detergent. The resulting supernatant is analyzed by FSEC (Fig. 3) . As shown in Figure 3 , removing the 64 residues from the C terminus of cASIC1 (cASIC1 ∆463) increases monodispersity and reduces cleavage of the GFP-His 8 tag. In addition to removing flexible termini, there are many methods that can be used to optimize the expression and stability of proteins, including codon optimization, surface entropy reduction and thermostability mutations [29] [30] [31] . Smallscale transfection followed by whole-cell solubilization and FSEC allows the screening of hundreds of candidates in ≤1 month.
Once a promising candidate is identified, the plasmid is transformed into the DH10Bac Escherichia coli strain to generate the recombinant bacmid DNA, which is then used to transfect insect cells to generate BacMam virus. We have detailed our methods for isolation of bacmid DNA, transfection of Sf9 cells and baculovirus amplification, which we use to reduce costs and ensure good-quality BacMam virus. We have found for some constructs that the multiplicity of infection (MOI) during virus amplification is 10-100-fold below the range recommended by the Bac-toBac system (Invitrogen) protocol (http://www.lifetechnologies. com/us/en/home/life-science/protein-expression-and-analysis/ protein-expression/insect-expression/bac-to-bac-baculovirusexpression-system.html). We have also found that a low MOI (MOI of 2 or less) is sufficient for mammalian cell transduction and that too much virus results in low cell numbers, possibly owing to too much Sf9 medium or virus added to the culture. Therefore, before virus amplification or transduction of mammalian cells for protein expression, virus titer should be determined using the endpoint dilution assay 32 , flow cytometric assay 33, 34 or the viral plaque assay 35 .
In addition to MOI, we also explored different growth and expression conditions for BacMam-transduced HEK293S GnTI − cells to boost protein expression. After testing several types of media for the growth of suspension cells, we found that the use of Gibco FreeStyle 293 expression medium (Invitrogen) allowed [36] [37] [38] [39] [40] [41] [42] [43] . In a time-course experiment for cASIC1, we found that at the optimal collection time of 72 h after transduction, there was a 4.3-fold increase in expression at 30 °C compared with that at 37 °C (Fig. 4a) . Gaussian fitting, as described previously 21, 22 , was performed on the FSEC profiles to determine the peak area of cASIC1 trimer. A graph of the trimer peak area shows that the expression of cASIC1 is higher at 30 °C than at 37 °C for most time points (Fig. 4b) . To monitor the expression of GluCl in HEK293S GnTI − cells, an EGFP GluCl gene fusion 25, 44 was cloned into pEG BacMam and used to generate BacMam virus. At the optimal collection time of 72 h after transduction for cells expressing GluCl, there was a 9.5-fold increase in expression at 30 °C with higher expression of GluCl at all time points at 30 °C (Fig. 4c,d ). To show that the proteins present in the major peaks for cASIC1 and GluCl are of the expected molecular weight, peak fractions were collected and analyzed by SDS-PAGE, followed by western blot analysis using an antibody against GFP (Fig. 4e) . In fact, for the expression of most proteins in HEK293S GnTI − cells, we have found that lowering the temperature during expression increases protein yields at least twofold (A.G., C.-H.L., K.H.W., J.C.M., D.P.C. and E.G., unpublished data). In some cases, lowering the temperature is essential in order to obtain monodisperse, well-folded protein.
Finally, the use of histone deacetylase inhibitors has been shown to enhance protein expression in HEK293S cells (refs. 10,45) . We found that for most membrane proteins histone deacetylase inhibitors boost expression. For cASIC1, there is a sevenfold increase in expression at 72 h after transduction, as well as higher expression of cASIC1 at all time points at which HEK293S GnTI − cells are treated with 10 mM sodium butyrate (Fig. 5a,b) . Previously published data suggest that valproic acid is more efficient than sodium butyrate at enhancing recombinant protein production from mammalian cells 45 . However, we find that both sodium butyrate and valproic acid enhance protein expression from BacMam-transduced HEK293S GnTI − cells (Fig. 5c) . Typically, sodium butyrate is added to cultures between 8 and 24 h after transduction; however, the amount and time of sodium butyrate addition should be optimized for each protein. Overall optimization of conditions (construct, MOI, cell density, temperature and collection time of BacMam-transduced HEK293S GnTI − cells) could either increase expression or decrease aggregation, leading to more properly folded protein, and therefore the most favorable conditions for each protein should be determined before attempting a large-scale expression.
Other applications of the method
The protocol described here could also be used to optimize the expression of heteromers or protein complexes in mammalian cells. One option to simultaneously express multiple proteins is to co-infect with multiple BacMam viruses (with an optimized MOI for each virus). Alternatively, pEG BacMam could be used to express multiprotein complexes by combining two pEG BacMam plasmids using unique restriction enzyme sites. As a result, multiple genes could be transduced by a single BacMam virus, allowing for the simultaneous expression of two or more genes. Some variants of pEG BacMam also contain vesicular stomatitis Indiana virus glycoprotein (VSIV-G) under control of the P10 promoter (a baculovirus-specific promoter). VSIV-G is a viral capsule protein important for mediating viral entry, and it has been shown to increase the transduction efficiency of baculovirus for some mammalian cells 46 . The P10 promoter could be used to drive the expression of VSIV-G in insect cells, allowing the incorporation of VSIV-G into the baculovirus to enhance transduction from other mammalian cell lines, such as the human lung carcinoma line A549 and the human hepatoma lines HepG2 and HuH7 (ref. 46) .
Comparison with other methods
Many methods have been used for the overexpression of mammalian proteins, including plasmid transfection, stable cell lines and viral expression systems such as Sindbis virus, vaccinia virus and Semliki Forest virus (SFV), as well as AcMNPV 47 . Compared with BacMam, each of these methods has advantages and disadvantages in terms of cost, time, efficiency, safety and reproducibility.
One such transient expression method involves transfection of plasmid DNA into adherent cells or cultures, and overexpression is either immediate or induced, depending on the promoter. Plasmid transfection is fast, safe and easy to use for high-throughput screening [48] [49] [50] . However, if commercial transfection reagents and plasmid isolation kits are used, plasmid transfection can be expensive for large-scale expression. Furthermore, the level of expression using plasmid transfection can be limited by the plasmid size, the number of plasmids transfected and cytotoxic effects that have been observed with many transfection reagents. The use of BacMam can be cheaper than plasmid transfection for large-scale expression and multiple rounds of expression. In addition, BacMam is not limited by the gene number or size. In our hands, the level of protein expression, especially multisubunit proteins, is higher with BacMam than with plasmid transfection.
Stable expression in mammalian cells requires the integration of a transfected transgene into the cell's genome using Geneticin or other selection methods. Once clonal cell lines are generated and sorted for high-level producers, long-term overexpression from stably transfected cells can be robust, easy and consistent 51, 52 . Furthermore, stable cell lines can be generated using regulated expression, such as the tetracycline-inducible expression system, thus allowing for large-scale expression of proteins that are cytotoxic to the cell 51, 53 . Although stable expression enables the production of large quantities of protein, when compared to BacMam generating a stable cell line is time consuming.
Although other viral expression systems for protein expression such as lentiviruses 54 , adenoviruses 55 , Sindbis virus 56, 57 , vaccinia virus 58 and SFV 59, 60 exist, SFV has been used to express a large number of membrane proteins consisting of mostly GPCRs 47 . To make virus, candidate genes are cloned into SFV plasmid and used as template for RNA synthesis. The RNA is then co-transfected (either using electroporation or liposome reagents) with helper RNA and packaged into SFV particles that can then be used to infect cells in culture. Although SFV can be easily used for small-scale studies by transfecting synthesized RNA into cells and by analyzing expression, using SFV for large cultures is more challenging than BacMam owing to the amount of RNA that is needed to make virus for large-scale studies. An effective method using BacMam was recently described to produce milligram quantities of proteins sufficient for crystallization 10 . However, the methods outlined therein to produce recombinant BacMam virus using the BD BaculoGold system are not as cost-efficient as the Bac-to-Bac method if multiple constructs are expected to be generated. In addition, we optimized growth and expression conditions using BacMam in order to express sufficient amounts of our desired membrane proteins.
Another commonly used method for the overexpression of proteins is AcMNPV baculovirus infection of insect cells.
Although insect cells such as Sf9 cells have been used in our laboratory previously to provide sufficient protein for crystallization studies 25, [61] [62] [63] [64] , some membrane proteins require a near-native environment to help ensure functional expression. The advantages for the expression of eukaryotic membrane proteins in mammalian cells over Sf9 include improved post-translational modifications such as N-linked glycosylation 65, 66 and a different lipid environment that contains higher amounts of cholesterol. We performed a side-byside comparison of protein expression from insect cells and mammalian cells. We found a twofold increase in cASIC1 trimer and an increase in homogeneity (Fig. 6a,b) , and we found that fivefold more GluCl pentamer can be obtained in mammalian cells (Fig. 6c,d ). (Fig. 2 BacMam virus titer determination Determine the titer of the BacMam virus using one of the several methods for virus titer determination. We prefer using the Sf9 Easy Titer cell line and the endpoint dilution assay 32 (Box 2) or the flow cytometric assay 33, 34 . EQUIPMENT SETUP FSEC In our laboratory, this is performed as described by Kawate and Gouaux 21 . The analyte is loaded onto a Superose 6 column (10/30, Amersham Biosciences) that has been pre-equilibrated with FSEC buffer. Separation is performed at a flow rate of 0.5 ml/min. The eluent from the SEC column is passed through a Shimadzu fluorometer (RF-20A) fitted with a flow cell, as described in the manufacturer's instructions. The fluorometer settings are as follows: band-pass, 3 nm/3 nm; excitation, 488 nm; emission, 507 nm; time increment, 1 s; integration time, 1 s; and recording time, 3,000-3,600 s. Calibration with known quantities of GFP have demonstrated that 1-10 ng of GFP can readily be detected.
MaterIals

REAGENTS
pEG BacMam plasmid containing the gene of interest in frame with a GFP tag and a tag appropriate for affinity chromatography (such as a His 8 tag) cloned downstream of the CMV promoter• • • • • • • • • • • • • • • • • • • • • • • • • G
Box 2 | Endpoint dilution assay • tIMInG 1 h
The following procedure is for one 96-well black plate that can be used to titer four viruses, and it is based on ref. 32 . Adjust the volumes as necessary. 3| Add 1 µg of Qiagen miniprep-purified DNA into 50 µl of Opti-MEM I in a separate 1.5-ml centrifuge tube.
Growth and maintenance of adherent
4|
Add DNA/Opti-MEM I mixture to the Opti-MEM/Lipofectamine mixture; gently mix and incubate it for 20 min at RT.
5|
Pipette the Opti-MEM I-DNA mixture dropwise onto 70-80% confluent HEK293S GnTI − cells. Ensure even dispersal.
6| After 8-24 h, replace the medium with DMEM plus 10 mM sodium butyrate.
7|
Incubate the cells at 37 °C with 5% CO 2 for 2 d.
screening the constructs by Fsec for monodispersity and expression level (day 4)
• tIMInG 3 h 8| Aspirate off the medium and wash the transfected adherent cells carefully with 2 ml of TBS.
9| Add 1 ml of TBS to each well, collect the cells and transfer them to a 1.5-ml centrifuge tube.
10|
Centrifuge the cells at 1,500g for 5 min at 4 °C.
11|
Remove the supernatant and resuspend the cell pellet in 200 µl of solubilization buffer.
12|
Nutate the samples for 1 h at 4 °C.
13|
Centrifuge the solubilized sample at 70,000g in a TL100 ultracentrifuge for 40 min at 4 °C.
14|
Collect the supernatant and analyze 50 µl by FSEC 21 . Allow 1 h for each sample to be analyzed by FSEC. Samples should be stored at 4 °C until analysis.
15|
Identify the best-expressed and monodisperse candidate via FSEC (Fig. 3 and Kawate and Gouaux 21 ).
transformation of DH10Bac E. coli (day 5)
• tIMInG 1 h 16| Transform purified plasmid DNA into DH10Bac E. coli for transposition into the bacmid, as described in the Bac-to-Bac system protocol (Invitrogen; http://www.lifetechnologies.com/us/en/home/life-science/protein-expression-andanalysis/protein-expression/insect-expression/bac-to-bac-baculovirus-expression-system.html).
Inoculation of bacmid-containing cultures (day 7)
• tIMInG 15 min 17| Inoculate 5 ml of LB medium containing 50 µg/ml kanamycin, 7 µg/ml gentamicin and 10 µg/ml tetracycline with a white colony, and allow the cells to grow overnight at 37 °C.
Isolation of bacmid (day 8)
• tIMInG 1 h 18| Centrifuge the cells for 10 min at 1,500g at RT.
19|
(Optional) Make a glycerol stock of the DH10Bac E. coli containing the bacmid DNA for future bacmid DNA isolation.
In an autoclaved 1.5-ml centrifuge tube, take 250 µl of cell suspension (from Step 17) and add 250 µl of sterile 50% (vol/vol) glycerol; mix it and store it for years at −80 °C.
20|
Discard the supernatant and resuspend the pellet in 200 µl of P1 (Qiagen kits). Transfer the suspension into a 1.5-ml centrifuge tube.
21|
Add 200 µl of P2 (included in Qiagen kits) and mix by inverting the centrifuge tube a few times. ! cautIon Do not vortex the samples, as this could shear the bacmid DNA.
22|
Add 200 µl of N3 (included in Qiagen kits) and mix by inverting the centrifuge tube a few times; centrifuge the tube for 10 min at 1,500g at RT.
23|
Transfer the supernatant to a 2-ml centrifuge tube, add 1 ml of isopropanol and gently invert the tube.
24|
Place the tube for 10 min in a −20 °C freezer.
25|
Centrifuge the tube at 1,500g for 15 min at RT.
26|
Remove the supernatant, and preserve the pellet. Add 1 ml of 70% (vol/vol) ethanol and wash the pellet by gently inverting the centrifuge tube.
27|
28|
Remove the supernatant and dry the pellet for 5 min. 
31|
Incubate the cells at 27 °C until they attach (~20 min).
32|
While waiting for the cells to attach, add 8 µl of Cellfectin II to 100 µl of Sf-900 III SFM medium in centrifuge tubes for each transfection.
33|
In a different centrifuge tube, add 1 µg of bacmid DNA to 100 µl of Sf-900 III SFM.
34|
Mix the Cellfectin II/Sf-900 III SFM media mixture and the bacmid DNA/Sf-900 III SFM mixture, and incubate for 30 min at RT.
35|
Change the medium in each well with 2 ml of Sf-900 III SFM medium, and add the Cellfectin II/DNA mixture dropwise onto the Sf9 cells. Ensure even dispersal.
36|
Incubate the cells for 72 h in a 27 °C incubator (make sure to have water inside the incubator to prevent strong evaporation of the medium).
37|
Collect the supernatant containing P1 virus (~2 ml from each well), and filter the medium containing P1 virus into a 2-ml centrifuge tube using a 3-ml syringe fitted with a small 0.2-µm filter. This is a stock of P1 virus that should be stored at 4 °C light protected for up to a month. Add 2% (vol/vol) FBS to the stabilized virus stock. It might also be helpful to use the titerless infected cells preservation and scale-up (TIPS) method 67 to preserve Sf9 cells infected with P1 virus.
38|
Determine the titer of the P1 BacMam virus using the Sf9 easy titer cell line and the end-point dilution assay or by using the Virus Counter 2100.
? trouBlesHootInG Infection of sf9 cells with p1 virus to produce p2 virus • tIMInG 2 h 39| On the basis of the desired volume of P2 virus, add P1 virus to an MOI of 0.1 to 0.0001 to Sf9 cells that are 1.0-1.5 × 10 6 cells per ml in an Erlenmeyer flask of the corresponding size.  crItIcal step For the amplification of some viruses, we have found that it is essential to infect at a lower MOI than recommended by the Bac-to-Bac system (Invitrogen). Therefore, it may be important to determine the optimal MOI for the virus amplification before making a large amount of P2 virus. ? trouBlesHootInG
40|
Incubate the Sf9 cells infected with the P1 virus for 96 h in a 27 °C orbital shaker at 115 r.p.m.  crItIcal step For the amplification of some viruses, the collection time of the P2 BacMam virus may need to be optimized. We advise initially trying 72 and 96 h.
41|
Centrifuge the cells at 8,000g for 15 min at 4 °C, and collect the supernatant containing P2 virus.
42|
Filter the supernatant using disposable 0.2-µm filters (50-ml Steriflip filters from Millipore for small amounts or 250-ml, 0.5 l or 1-liter Corning filter systems for large amounts). Add 2% (vol/vol) FBS to the stabilized virus stock. This is a stock of P2 virus that should be stored at 4 °C, protected from light (we use aluminum foil) for up to 1 month.
43|
Determine the titer of the P2 BacMam virus using the Sf9 Easy Titer cell line and the endpoint dilution assay or by using the Virus Counter 2100. 
47|
Aseptically add the appropriate volume of prewarmed growth medium into the culture flask (the total volume should be 800 ml in a 2-liter flask). Split the culture to multiple flasks as needed, and incubate the cells on an orbital shaker within a 37 °C incubator in the presence of 8% CO 2 for ~5-6 d until the cells reach a density of 2-3.5 × 10 6 cells per ml.
48| Add BacMam P2 virus at an MOI of 1 to infect 2.4 liters of HEK293S GnTI − cells at a density of 2-3.5 × 10 6 cells per ml, and incubate the cells on an orbital shaker within a 37 °C incubator in the presence of 8% CO 2 .  crItIcal step The amount of virus added should not exceed >10% of the culture volume.
49| After 8-24 h at 37 °C, add 10 mM sodium butyrate and incubate the cells on an orbital shaker within a 30 °C incubator in the presence of 8% CO 2 .  crItIcal step The incubation temperature for the BacMam-transduced HEK293S GnTI − cells should be determined before attempting a large-scale expression (Fig. 4) . In addition, the amount and time of sodium butyrate addition should be optimized for each protein (Fig. 5) .
50| Collect the cells 60-90 h after transduction by centrifugation for 20 min at 6,200g at 4 °C.  crItIcal step The collection time of BacMam-transduced HEK293S GnTI − cells should be determined before attempting a large-scale expression (Fig. 4) . ? trouBlesHootInG  pause poInt The cell pellets can be stored at −80 °C for weeks until you are ready to proceed with protein purification [15] [16] [17] 20 .
? trouBlesHootInG Troubleshooting advice can be found in table 1.
• tIMInG The entire protocol, starting from transfection (Step 1) to the collection of BacMam virus-transduced suspension HEK293S GnTI − cells (Step 50), takes ~3 weeks to complete if a promising candidate is identified (Step 14). The hands-on timing for each stage of the PROCEDURE is summarized below.
Step antIcIpateD results This protocol (as outlined in Fig. 1 ) has been used in our laboratory to successfully express cASIC1, Drosophila melanogaster dopamine transporter (DAT), N-methyl-d-aspartate (NMDA) receptors and many other membrane proteins in HEK293S GnTI − cells 15, 16, 20, 61 . The time it takes to identify a promising candidate (Fig. 3) is likely to vary substantially depending on (for example) the number of flexible regions to be removed, surface entropy reduction mutations and thermostability mutations. Although few changes are made for cASIC1, several construct changes were needed for DAT and NMDA to obtain the best-expressed and monodisperse candidate via FSEC [15] [16] [17] 20 . Once a promising candidate is identified, the most favorable conditions for MOI, cell density, expression time, temperature (Fig. 4) and the presence of histone deacetylase inhibitors (i.e., sodium butyrate; Fig. 5 ) should be determined for each protein before attempting a large-scale expression.
The protocol for optimized expression can be completed in ~3 weeks. Purification of membrane proteins from transduced HEK293S GnTI -cell pellets (which may include affinity chromatography, tag cleavage, removal of N-linked glycosylation and size-exclusion chromatography), depending on the candidate protein, can produce 0.25-1.5 mg of protein per liter of medium sufficient for crystallization. The protein expression and yield can vary depending on factors such as the titer of the virus, the toxicity of the protein when expressed and the stability of the protein.
